Corticobasal Syndrome in a Patient with Anti‐IgLON5 Antibodies
- 14 April 2020
- journal article
- case report
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 7 (5) , 557-559
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Japanese multicenter database of healthy controls for [123I]FP-CIT SPECTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- Clinical manifestations of the anti-IgLON5 diseaseNeurology, 2017
- Neuropathological criteria of anti-IgLON5-related tauopathyActa Neuropathologica, 2016
- A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem studyThe Lancet Neurology, 2014
- Criteria for the diagnosis of corticobasal degenerationNeurology, 2013
- Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratioEuropean Journal of Nuclear Medicine and Molecular Imaging, 2006